|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gridelli C, Rossi A, Carbone DP, Guarize
J, Karachaliou N, Mok T, Petrella F, Spaggiari L and Rosell R:
Non-small-cell lung cancer. Nat Rev Dis Primers. 1:150092015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Song Q, Shang J, Yang Z, Zhang L, Zhang C,
Chen J and Wu X: Identification of an immune signature predicting
prognosis risk of patients in lung adenocarcinoma. J Transl Med.
17:702019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Travis WD: Lung cancer pathology: Current
concepts. Clin Chest Med. 41:67–85. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma F, Hou L and Yang L: Txndc9 is required
for meiotic maturation of mouse oocytes. Biomed Res Int.
2017:62658902017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang CH, Park JH, Lee ES, Paeng SK, Chae
HB, Hong JC and Lee SY: Redox-dependent structural modification of
nucleoredoxin triggers defense responses against alternaria
brassicicola in arabidopsis. Int J Mol Sci. 21:91962020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feng T, Zhao R, Sun F, Lu Q, Wang X, Hu J,
Wang S, Gao L, Zhou Q, Xiong X, et al: TXNDC9 regulates oxidative
stress-induced androgen receptor signaling to promote prostate
cancer progression. Oncogene. 39:356–367. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu A, Wangpu X, Han D, Feng H, Zhao J, Ma
J, Qu S, Chen X, Liu B and Zheng M: TXNDC9 expression in colorectal
cancer cells and its influence on colorectal cancer prognosis.
Cancer Invest. 30:721–726. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen D, Zou J, Zhao Z, Tang X, Deng Z, Jia
J and Liu S: TXNDC9 promotes hepatocellular carcinoma progression
by positive regulation of MYC-mediated transcriptional network.
Cell Death Dis. 9:11102018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aitken A: 14-3-3 proteins: A historic
overview. Semin Cancer Biol. 16:162–172. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho E and Park JY: Emerging roles of
14-3-3γ in the brain disorder. BMB Rep. BMB Rep. 53:500–511. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ni J, Wang J, Fu Y, Yan C, Zhu M, Jiang Y,
Chen J, Ding Y, Fan X, Li G and Jin G: Functional genetic variants
in centrosome-related genes CEP72 and YWHAG confer susceptibility
to gastric cancer. Arch Toxicol. 94:2861–2872. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim JO, Kim SR, Lim KH, Kim JH, Ajjappala
B, Lee HJ, Choi JI and Baek KH: Deubiquitinating enzyme USP37
regulating oncogenic function of 14-3-3γ. Oncotarget.
6:36551–36576. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang P, Deng Y and Fu X: MiR-509-5p
suppresses the proliferation, migration, and invasion of non-small
cell lung cancer by targeting YWHAG. Biochem Biophys Res Commun.
482:935–941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Denisenko TV, Budkevich IN and Zhivotovsky
B: Cell death-based treatment of lung adenocarcinoma. Cell Death
Dis. 9:1172018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang C, Zhang Z, Zhang G, Zhang Z, Luo Y,
Wang F, Wang S, Che Y, Zeng Q, Sun N and He J: Clinical
significance and inflammatory landscapes of a novel
recurrence-associated immune signature in early-stage lung
adenocarcinoma. Cancer Lett. 479:31–41. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu J, Li T, Wu H and Xu T: Role of
thioredoxin in lung disease. Pulm Pharmacol Ther. 25:154–162. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan J, Yu H, Lv Y and Yin L: Diagnostic
and prognostic value of serum thioredoxin and DJ-1 in non-small
cell lung carcinoma patients. Tumour Biol. 37:1949–1958. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou W, Fang C, Zhang L, Wang Q, Li D and
Zhu D: Thioredoxin domain-containing protein 9 (TXNDC9) contributes
to oxaliplatin resistance through regulation of autophagy-apoptosis
in colorectal adenocarcinoma. Biochem Biophys Res Commun.
524:582–588. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Y, Ye H, Peng B, Jiang H, Tang Q, Liu
Y, Xi J and Chen S: MiR-643 functions as a potential tumor
suppressor in gastric cancer by inhibiting cell proliferation and
invasion via targeting TXNDC9. Ann Clin Lab Sci. 51:494–502.
2021.PubMed/NCBI
|
|
24
|
Garcia SA and Nagai MA: Transcriptional
regulation of bidirectional gene pairs by 17-β-estradiol in MCF-7
breast cancer cells. Braz J Med Biol Res. 44:112–122. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Raungrut P, Wongkotsila A,
Lirdprapamongkol K, Svasti J, Geater SL, Phukaoloun M, Suwiwat S
and Thongsuksai P: Prognostic significance of 14-3-3γ
overexpression in advanced non-small cell lung cancer. Asian Pac J
Cancer Prev. 15:3513–3518. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Holmes TR, Al-Matouq J, Holmes M, Nicola
L, Rudd JC, Lovas S and Hansen LA: Targeting 14-3-3ε-CDC25A
interactions to trigger apoptotic cell death in skin cancer.
Oncotarget. 11:3267–3278. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hiraoka E, Mimae T, Ito M, Kadoya T,
Miyata Y, Ito A and Okada M: Correction to: Breast cancer cell
motility is promoted by 14-3-3γ. Breast Cancer. 26:5942019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qi W, Liu X, Chen W, Li Q and Martinez JD:
Overexpression of 14-3-3gamma causes polyploidization in H322 lung
cancer cells. Mol Carcinog. 46:847–856. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qi W, Liu X, Qiao D and Martinez JD:
Isoform-specific expression of 14-3-3 proteins in human lung cancer
tissues. Int J Cancer. 113:359–363. 2005. View Article : Google Scholar : PubMed/NCBI
|
